TrialResults - center   -  Clinical trials results database in cardiology

GAMMA

You are here:  Home > revascularization with drug eluting stent in coronary artery disease

revascularization with drug eluting stent in coronary artery disease - Clinical trials results

Systematic review and meta-analysis of clinical trials about revascularization with drug eluting stent in coronary artery disease.

Clinical trials enrolled the following type of patients :

• all type of patients
• diabetic patients
• acute myocardial infarction
• long or complex lesion
• bypass graft lesion
• in stent restenosis
• unprotected left main artery stenosis
• bifurcation lesion
• unparticular patients
• total occlusion
• small vessels

See also:

• revascularization with drug eluting stent trial results (all clinical conditions)
• coronary artery disease trial results (all therapeutical action or mecanism)

Other revascularization with drug eluting stent:  biodegradable-polymer rapamycin stent , biolimus A9 , biolimus ES , CoStar stent , crush stenting , dactinomycin ES , dexamethasone ES , drug ES , dual rapamycin, probucol ES , everolimus ES , Genous stent , kissing balloon , paclitaxel eluting balloon , paclitaxel ES , paclitaxel, non-polymeric ES , pimecrolimus ES , polymer free rapamycin stent , sirolimus biodegradable polymer , sirolimus ES , zotarolimus ES ,

Entry term : Coronary Artery Disease, angor, stable angina, Coronary Arteriosclerosis, Coronary Atherosclerosis, Myocardial Ischemia, Ischemic Heart Diseases, , Drug Coated Stents, Drug-Eluting Stents

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/3 27 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar